logo

EVGN

Evogene·NASDAQ
--
--(--)
--
--(--)
4.97 / 10
Netural

Fundamental breakdown reveals fair profile (5.0/10). Supportive elements: PB-ROE and Asset-MV, whereas limitations surface in Gross profit margin (%) and Current assets turnover ratio. This suggests selective positioning.

Fundamental(4.97)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.94
Score3/3
Weight38.26%
1M Return21.41%
Inventory turnover ratio
Value0.92
Score2/3
Weight-2.47%
1M Return-2.37%
Gross profit margin (%)
Value48.86
Score1/3
Weight0.22%
1M Return0.22%
Profit-MV
Value0.47
Score2/3
Weight10.81%
1M Return7.95%
Net income-Revenue
Value3.93
Score2/3
Weight10.95%
1M Return8.04%
PB-ROE
Value-0.75
Score2/3
Weight15.79%
1M Return11.23%
Current assets turnover ratio
Value0.17
Score1/3
Weight0.30%
1M Return0.27%
Fixed assets turnover ratio
Value2.36
Score2/3
Weight0.03%
1M Return0.03%
Asset-MV
Value-0.51
Score2/3
Weight15.40%
1M Return9.85%
Cash-MV
Value-0.07
Score2/3
Weight10.71%
1M Return7.78%
Is EVGN undervalued or overvalued?
  • EVGN scores 4.97/10 on fundamentals and holds a Fair valuation at present. Backed by its -19.79% ROE, -48.76% net margin, -0.66 P/E ratio, 0.55 P/B ratio, and 96.86% earnings growth, these metrics solidify its Netural investment rating.